Should Investors Buy Oscar Health Stock Right Now?

Source Motley_fool

Healthcare stocks have been under pressure in the U.S. due to increasing regulatory headwinds and rising costs.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

*Stock prices used were the afternoon prices of May 13, 2025. The video was published on May 15, 2025.

Should you invest $1,000 in Oscar Health right now?

Before you buy stock in Oscar Health, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oscar Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $620,719!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $829,511!*

Now, it’s worth noting Stock Advisor’s total average return is 959% — a market-crushing outperformance compared to 170% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of May 12, 2025

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Bitcoin Must Clear This Critical Cost Basis Level For Continued Upside, Analyst SaysIn a recent CryptoQuant Quicktake post, contributor Crazzyblockk highlighted key Bitcoin (BTC) cost basis zones that the leading cryptocurrency must clear – or avoid breaking below – to
Author  NewsBTC
4 Month 23 Day Wed
In a recent CryptoQuant Quicktake post, contributor Crazzyblockk highlighted key Bitcoin (BTC) cost basis zones that the leading cryptocurrency must clear – or avoid breaking below – to
placeholder
Top 3 gainers EOS, Kaito, Stacks: Navigating the dynamic altcoin marketThe altcoin market is getting more complex to navigate, with fragmented narratives, limited liquidity, and massive token unlocks creating hefty headwinds.
Author  FXStreet
5 Month 08 Day Thu
The altcoin market is getting more complex to navigate, with fragmented narratives, limited liquidity, and massive token unlocks creating hefty headwinds.
placeholder
Gold price bears flirt with 200-period EMA pivotal support on H4 amid US-China trade optimismGold price (XAU/USD) struggles to capitalize on the previous day's modest uptick and attracts fresh sellers during the Asian session on Wednesday.
Author  FXStreet
5 Month 14 Day Wed
Gold price (XAU/USD) struggles to capitalize on the previous day's modest uptick and attracts fresh sellers during the Asian session on Wednesday.
placeholder
BNB Price Forecast: BNB recovery receives boost as trading volume hits $11.35 billion, highest yearly levelBNB (BNB) is extending its recovery, trading around $670 on Tuesday after rebounding from a key level over the weekend. On-chain data and technical outlook suggest a rally ahead as BNB breaks above the symmetrical triangle pattern, with ecosystem trading volume and stablecoin activity surging.
Author  FXStreet
6 Month 03 Day Tue
BNB (BNB) is extending its recovery, trading around $670 on Tuesday after rebounding from a key level over the weekend. On-chain data and technical outlook suggest a rally ahead as BNB breaks above the symmetrical triangle pattern, with ecosystem trading volume and stablecoin activity surging.
placeholder
Ripple May Be Releasing XRP Liquidity Via Backdoor, Claims Crypto PunditA provocative claim by crypto researcher “Darkhorse” has reignited debate over whether Ripple Labs is quietly sidestepping a federal court injunction through a newly disclosed $300 million XRP
Author  NewsBTC
6 Month 06 Day Fri
A provocative claim by crypto researcher “Darkhorse” has reignited debate over whether Ripple Labs is quietly sidestepping a federal court injunction through a newly disclosed $300 million XRP
goTop
quote